BIOPOWERTECH

Company Information

Company Name
BIOPOWERTECH
Address
BIOPOWERTECH
4734 BLUEGRASS PKY
TUSCALOOSA, AL, 35406 4040
Phone
n/a
URL
n/a
DUNS
603569331
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
Y

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,312,963.00
7

Award List

  1. Development of recombinant rhTL1A protein for cancer treatment

    Amount: $329,560.00

    DESCRIPTION (provided by applicant): Breast cancer is the most common cause of cancer in women and the second most common cause of cancer death in women in the United States. In 2009, approximately 40 ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. Decoy receptor 3 and liver cirrhosis

    Amount: $109,681.00

    DESCRIPTION (provided by applicant): Liver cirrhosis is a chronic and degenerative disease that can lead to inability of the liver to perform its biochemical function thus severely affecting the quali ...

    SBIR Phase I 2006 Department of Health and Human Services
  3. A therapeutic potential of soluble decoy receptor 3 in sepsis

    Amount: $112,572.00

    DESCRIPTION (provided by applicant): Sepsis a serious life-threatening condition resulting from a harmful inflammatory reaction of the body due to bacterial infection. The mortality rate of sepsis re ...

    SBIR Phase I 2006 Department of Health and Human Services
  4. Soluble Decoy Receptor 3 in Bacterial Infection and Sepsis

    Amount: $107,000.00

    DESCRIPTION (provided by applicant): Sepsis is a serious inflammatory reaction of the body due to bacterial infection, and the mortality rate of severe sepsis is high in intensive care units around th ...

    SBIR Phase I 2006 Department of Health and Human Services
  5. Development of immunoassay to measure a novel TNF-like protein

    Amount: $115,389.00

    DESCRIPTION (provided by applicant): The tumor necrosis factor (TNF) family cytokines (ligands) mediate diverse immune responses via the activation of their cognate receptors expressed on the cell sur ...

    SBIR Phase I 2007 Department of Health and Human Services
  6. A novel therapy for sepsis

    Amount: $203,439.00

    Description: (Provided by Applicant) Sepsis a serious life-threatening condition resulting from a harmful inflammatory reaction of the body due to bacterial infection. The mortality rate of sepsis rem ...

    SBIR Phase I 2007 Department of Health and Human Services
  7. Targeting Deceoy Receptor 3 in Breast Cancer

    Amount: $335,322.00

    DESCRIPTION (provided by applicant): Breast cancer is the leading cause of cancer deaths in the United States. In this year alone, approximately 40,480 women in the US are estimated to die from breast ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government